SMid Cap Biotech Analyst Romero, along with CEO Adams, CFO Schneyer and COO Teehan, hold a post 3Q24 reported earnings conference call on November 7 at 11:30 am. Webcast Link
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACAD:
- Acadia Pharmaceuticals Sees Revenue Growth and Strategic Advances
- Acadia Pharmaceuticals reports Q3 EPS , consensus 14c
- Acadia Pharmaceuticals sees FY24 revenue $940M-$960M, consensus $952.5M
- Acadia Pharma sells Rare Pediatric Disease Priority Review Voucher for $150M
- ACAD Upcoming Earnings Report: What to Expect?